[2023 review] What are the 10 strongest stocks in the US stock market?

・Generative AI boomRice on $NVIDIA(NVDA.US)$IsUp close to 240% year to dateI did it. Other than that, although it is not well known, it is as promising as NVIDIA $Super Micro Computer(SMCI.US)$Is the beginning of the yearAn increase of approximately 280%. Major data center $Vertiv Holdings(VRT.US)$Is260% or more, a major data analysis company $Palantir(PLTR.US)$too179% or morerise.

・Intensification of US Fed rate cut observationsetc. became a tailwind, and major postpaid settlement services $Affirm Holdings(AFRM.US)$What is the stock price ofSoared more than 400%Then,It came in 1st place. What is remarkable is that the company has been around since NovemberA rate of increase of 186%It has been recorded.

・ $Coinbase(COIN.US)$The stock price of is year-to-dateAn increase of approximately 355%I did, and last month61% increaseIt was recorded. The background is the backlash in the crypto asset (virtual currency) market and the US authoritiesExpectations for approval of spot Bitcoin exchange-traded funds (ETFs)There is.

・It is a mobile application development and sales company $Applovin(APP.US)$The stock price of has been boosted by the development of new AI tools this year, and since the beginning of the yearMore than 300% increase、It came in 3rd place. The company is rapidly growing its revenue and number of users. One of the main drivers of success is a diversified game portfolio spanning different genres, platforms, and markets. The other is an innovative technology platform that enables effective user acquisition, monetization, and analysis.

Also, since the second half of this year, the weight loss drug market has been growing rapidly. According to Goldman analysts, the obesity market in 2030 will be $Eli Lilly and Co(LLY.US)$with $Novo-Nordisk A/S(NVO.US)$Butabout 80%Occupy,2 becomes a strong oligopolyIt's called. “There is a possibility that dominant leadership will continue at this level.” Both companies' stock prices have risen rapidly this year. Eli LillyApproximately 60% since the beginning of the year, Novo Nordiskclose to 50%rise.